Foundation Medicine Seeks "Go-To" Companion Diagnostic Status For Sequencing Test

The firm is barely more than a year old, but Cambridge, Mass.-based Foundation Medicine has set its sights on offering a one-stop companion diagnostic for cancer treatments using next-generation genome sequencing.